Rimexolone

利美索龙

Report date: 2026/03/09 20:02:04
NME

Base Information

Drug NameRimexolone
Drug Alias NameRimexolonum利每索龙Trimexolone双甲丙酰龙瑞美松龙 +[12] 
ClassificationSmall molecules > Steroids
Mechanisms of ActionGlucocorticoid receptor agonists
TargetsGlucocorticoid receptor
Therapy Area/IndicationsPostoperative inflammationUveitisXerophthalmia
Global Approved IndicationsPostoperative inflammationUveitis
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1994/12/30
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesAlcon
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHarrow Eye LLCAlcon
Active IndicationsN/A
Inactive IndicationsPostoperative inflammationUveitisXerophthalmia

Other Information

ATC CodeH02AB12S01BA13
Related LinksWikipediaDrugBankKEGG